This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Suda, S. Articles by Ferrier, C. Search for Related Content PubMed PubMed Citation Articles by Suda, S. Articles by Ferrier, C.

Hypertension, Vol 11, 483-490, Copyright © 1988 by American Heart Association

ARTICLES

Atrial natriuretic factor in mild to moderate chronic renal failure

S Suda, P Weidmann, H Saxenhofer, C Cottier, SG Shaw and C Ferrier
Medizinische Poliklinik, University of Berne, Switzerland.

The relationship between kidney function and plasma immunoreactive atrial natriuretic factor (irANF) levels as well as the effects of synthetic human ANF-(99-126) were investigated in 13 patients with mild to moderate chronic renal failure. Under basal conditions, glomerular filtration rate averaged 39 +/- 5 (SEM) ml/min/1.73 m2 and blood pressure (BP) averaged 166/107 +/- 7/2 mm Hg; 12 patients were hypertensive. Plasma irANF levels were significantly increased (98 +/- 16 vs 42 +/- 4 pg/ml in healthy control subjects; p less than 0.001) and correlated (p less than 0.05-0.005) inversely with hematocrit (r = - 0.65) and positively with systolic BP (r = 0.75) or fractional sodium excretion (r = 0.75). Human ANF-(99-126) infusion for 45 minutes at 0.034 microgram/kg/min augmented (p less than 0.05-0.01) diuresis and urinary sodium, chloride, calcium, phosphate, and magnesium excretion. During the subsequent 45 minutes of human ANF-(99-126) infusion at a rate of 0.077 microgram/kg/min, diuresis and electrolyte excretion remained elevated (p less than 0.05-0.01). Glomerular filtration rate and effective renal plasma flow were not significantly modified, but filtration fraction rose progressively (p less than 0.01). Human ANF- (99-126) infusion decreased BP (p less than 0.05-0.01), produced hemoconcentration (hematocrit + 7%; p less than 0.01) without negative body fluid balance, and increased (p less than 0.01-0.001) plasma norepinephrine, insulin, and serum free fatty acids; plasma aldosterone and renin activity were unaltered during but rose after cessation of human ANF-(99-126) infusion.(ABSTRACT TRUNCATED AT 250 WORDS)

This article has been cited by other articles:

				C. Santos-Araujo, R. Roncon-Albuquerque Jr, M. Moreira-Rodrigues, T. Henriques-Coelho, J. Quelhas-Santos, B. Faria, B. Sampaio-Maia, A. F. Leite-Moreira, and M. Pestana Local modulation of the natriuretic peptide system in the rat remnant kidney Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1774 - 1782. [Abstract] [Full Text] [PDF]

				Y. Yano, A. Katsuki, E. C. Gabazza, K. Ito, M. Fujii, M. Furuta, K. Tuchihashi, H. Goto, K. Nakatani, Y. Hori, et al. Plasma Brain Natriuretic Peptide Levels in Normotensive Noninsulin-Dependent Diabetic Patients with Microalbuminuria J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2353 - 2356. [Abstract] [Full Text]